Literature DB >> 17826932

Vestibular evoked myogenic potentials of undiagnosed dizziness.

Toru Seo1, Atsushi Miyamoto, Michiko Node, Masafumi Sakagami.   

Abstract

OBJECTIVE: Recording of vestibular evoked myogenic potentials (VEMP) can facilitate the evaluation of otolith function. The dizziness caused by otolith lesions is not completely understood. To clarify which symptoms of dizziness originate from the otolith organs, we examined the relationship between symptoms and VEMP results in patients with undiagnosed dizziness.
METHODS: The subjects were 18 patients with undiagnosed dizziness aged less than 40 years who underwent VEMP examination. The VEMP results were evaluated using the interaural ratio of p13-n23 amplitude.
RESULTS: Abnormal VEMP results were obtained in five of seven patients who experienced a sensation of falling (p=0.013), in none of the three patients who experienced a swaying sensation (p>0.05), and in one of eight patients who experienced a floating sensation (p>0.05). Five of six patients with abnormal VEMP results complained of disequilibrium lasting a few seconds.
CONCLUSIONS: Dizziness with a sensation of falling lasting for a few seconds was related to abnormal VEMP results, suggesting that it resulted from saccular dysfunction. VEMP examination may be considered a useful modality in the diagnosis of dizziness of unknown origin.

Entities:  

Mesh:

Year:  2007        PMID: 17826932     DOI: 10.1016/j.anl.2007.04.006

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  2 in total

1.  Vestibular functions in motion sickness susceptible individuals.

Authors:  Fuat Buyuklu; Erkan Tarhan; Levent Ozluoglu
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-02-26       Impact factor: 2.503

2.  Vestibular-evoked myogenic potential in response to bone-conducted sound in patients with otosclerosis.

Authors:  Naoki Saka; Toru Seo; Kiyoko Fujimori; Yasuo Mishiro; Masafumi Sakagami
Journal:  Acta Otolaryngol       Date:  2012-07-25       Impact factor: 1.494

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.